Vericel Corp (VCEL)
56.72
-0.54
(-0.94%)
USD |
NASDAQ |
Nov 21, 16:00
56.72
0.00 (0.00%)
After-Hours: 20:00
Vericel Price to Book Value: 10.87 for Nov. 21, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 20, 2024 | 10.98 |
| November 19, 2024 | 10.70 |
| November 18, 2024 | 10.14 |
| November 15, 2024 | 10.06 |
| November 14, 2024 | 10.11 |
| November 13, 2024 | 10.63 |
| November 12, 2024 | 10.71 |
| November 11, 2024 | 10.88 |
| November 08, 2024 | 10.35 |
| November 07, 2024 | 9.591 |
| November 06, 2024 | 9.210 |
| November 05, 2024 | 8.579 |
| November 04, 2024 | 8.506 |
| November 01, 2024 | 8.433 |
| October 31, 2024 | 8.443 |
| October 30, 2024 | 8.714 |
| October 29, 2024 | 8.769 |
| October 28, 2024 | 8.737 |
| October 25, 2024 | 8.371 |
| October 24, 2024 | 8.203 |
| October 23, 2024 | 8.090 |
| October 22, 2024 | 8.004 |
| October 21, 2024 | 7.879 |
| October 18, 2024 | 7.971 |
| October 17, 2024 | 7.782 |
| Date | Value |
|---|---|
| October 16, 2024 | 7.897 |
| October 15, 2024 | 8.027 |
| October 14, 2024 | 8.054 |
| October 11, 2024 | 7.977 |
| October 10, 2024 | 7.671 |
| October 09, 2024 | 7.835 |
| October 08, 2024 | 7.912 |
| October 07, 2024 | 7.856 |
| October 04, 2024 | 8.297 |
| October 03, 2024 | 7.912 |
| October 02, 2024 | 7.788 |
| October 01, 2024 | 7.663 |
| September 30, 2024 | 8.084 |
| September 27, 2024 | 8.715 |
| September 26, 2024 | 8.893 |
| September 25, 2024 | 8.919 |
| September 24, 2024 | 9.028 |
| September 23, 2024 | 9.357 |
| September 20, 2024 | 9.397 |
| September 19, 2024 | 9.692 |
| September 18, 2024 | 9.353 |
| September 17, 2024 | 8.943 |
| September 16, 2024 | 9.024 |
| September 13, 2024 | 9.256 |
| September 12, 2024 | 8.933 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
2.933
Minimum
Mar 18 2020
22.42
Maximum
Jun 28 2021
9.595
Average
8.449
Median
Price to Book Value Benchmarks
| Catalyst Pharmaceuticals Inc | 3.812 |
| Exelixis Inc | 4.371 |
| Halozyme Therapeutics Inc | 12.85 |
| ADMA Biologics Inc | 21.71 |
| Natera Inc | 25.46 |
Price to Book Value Related Metrics
| PE Ratio | 810.29 |
| PS Ratio | 12.11 |
| Price | 56.72 |
| Earnings Yield | 0.12% |
| Market Cap | 2.800B |
| Normalized PE Ratio | 810.29 |